Literature DB >> 6094617

Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.

R J Marshall, A Herbert, S G Braye, D B Jones.   

Abstract

Antibodies raised against human milk fat globule (HMFG 1 and 2) and carcinoembryonic antigen were used in an immunoperoxidase technique to differentiate mesothelioma, carcinoma, and benign, reactive mesothelium. Sixteen mesotheliomas, 27 lung carcinomas, and 13 specimens of reactive mesothelium were examined. Staining for carcinoembryonic antigen was not seen in reactive mesothelium or mesothelioma but was present in 22 of 27 carcinomas. Mesothelioma and carcinoma usually stained with HMFG 1 and 2; reactive mesothelium did not. These three antibodies may help to distinguish carcinoma, mesothelioma, and reactive mesothelium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094617      PMCID: PMC498986          DOI: 10.1136/jcp.37.11.1215

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

Review 1.  Asbestos and mesothelioma: a review.

Authors:  M Kannerstein; J Churg; W T McCaughey
Journal:  Pathol Annu       Date:  1978

2.  Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens.

Authors:  D M Goldenberg; R M Sharkey; F J Primus
Journal:  Cancer       Date:  1978-09       Impact factor: 6.860

3.  The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique.

Authors:  B L Mepham; W Frater; B S Mitchell
Journal:  Histochem J       Date:  1979-05

4.  Carcinoembryonic antigen in tissue diagnosis of malignant mesothelioma.

Authors:  D Whitaker; K B Shilkin
Journal:  Lancet       Date:  1981-06-20       Impact factor: 79.321

5.  Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.

Authors:  J Taylor-Papadimitriou; J A Peterson; J Arklie; J Burchell; R L Ceriani; W F Bodmer
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

6.  Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers.

Authors:  N S Wang; S N Huang; P Gold
Journal:  Cancer       Date:  1979-09       Impact factor: 6.860

7.  Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.

Authors:  A A Epenetos; G Canti; J Taylor-Papadimitriou; M Curling; W F Bodmer
Journal:  Lancet       Date:  1982-11-06       Impact factor: 79.321

8.  Carcinoembryonic antigen: immunohistologic identification in invasive and intraepithelial carcinomas of the lung.

Authors:  R R Pascal; R Mesa-Tejada; S J Bennett; A Garces; C M Fenoglio
Journal:  Arch Pathol Lab Med       Date:  1977-11       Impact factor: 5.534

9.  Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.

Authors:  J M Corson; G S Pinkus
Journal:  Am J Pathol       Date:  1982-07       Impact factor: 4.307

10.  Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers.

Authors:  J Arklie; J Taylor-Papadimitrious; W Bodmer; M Egan; R Millis
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

View more
  20 in total

1.  Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.

Authors:  A Linari; G Bussolati
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

Review 2.  Malignant mesothelioma.

Authors:  R Rudd
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

3.  New marker for mesothelioma: an immunoperoxidase study.

Authors:  A Donna; P G Betta; D Bellingeri; A Marchesini
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

4.  Immunohistochemistry in the diagnosis of malignant mesothelioma.

Authors:  M Pfaltz; B Odermatt; B Christen; J R Rüttner
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.

Authors:  K Sheibani; H Battifora; J S Burke
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

6.  Diagnosing tumours on routine surgical sections by immunohistochemistry: use of cytokeratin, common leucocyte, and other markers.

Authors:  R N Poston; Y S Sidhu
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

7.  Differences in lectin binding of malignant pleural mesothelioma and adenocarcinoma of the lung.

Authors:  T Kawai; S D Greenberg; L D Truong; C A Mattioli; M Klima; J L Titus
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

8.  Immunohistochemical expression of MAM-3 and MAM-6 antigens in salivary gland tumours.

Authors:  K Yamada; T Tanaka; M Mori; A Tsubura; S Morii; M Tsubone; C Ando; J Hilgers
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

9.  Dysphagia due to mesothelioma infiltrating the oesophagus: palliative treatment.

Authors:  C A Lockwood; H W Jones; C K Foote; M J Turner
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

10.  Monoclonal antibodies to human malignant mesothelioma.

Authors:  T M Anderson; E C Holmes; C J Kosaka; L Cheng; R E Saxton
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.